A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer's prevention & treatment.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic, preclinical, and clinical literature.
PubMed 34929348 · doi:10.1016/j.arr.2021.101542
What was done
This narrative review synthesized mechanistic, preclinical, and clinical research examining female midlife brain aging across three phases: early chronological (pre-menopause), endocrinological (peri-menopause), and late chronological (post-menopause). The authors evaluated how metabolic and immune signaling networks interact during endocrine aging and how these pathways, modulated by APOE4 genotype, contribute to late-onset Alzheimer's disease (AD) pathogenesis.
What was found
The abstract reports no quantitative values or statistical effect sizes. Mechanistically, the dismantling of estrogenic control over glucose metabolism drives an adaptive starvation response shifting the brain to ketone body utilization via astrocytic beta-oxidation of white matter lipids. This bioenergetic transition triggers dynamic neuroimmune alterations, which are accelerated in the presence of the APOE4 allele, establishing a critical transition window for late-onset AD pathogenesis.
Why it matters
The review frames the perimenopausal transition as a defined mechanistic window where targeted metabolic and immune interventions might mitigate long-term Alzheimer's risk. It highlights the biological necessity of including chromosomal sex and endocrine transition stage in precision medicine frameworks for neurodegenerative disease.
Limits
The paper is a narrative overview rather than a systematic review or meta-analysis, providing no original human trial data, quantitative effect estimates, or quality assessments of included studies. Mechanistic findings derived from female endocrine transitions cannot be directly applied to male brain aging pathways.
Cited by
- supports Estradiol specifically is critical for the brain's ability to utilize glucose for energy, and reductions in estradiol during perimenopause and menopause impair brain energy metabolism.